What is ADMA Biologics's revenue?

ADMA Biologics (ADMA) generated $509.9M in revenue over the trailing twelve months, up 11.0% year over year.

Is ADMA Biologics profitable?

ADMA Biologics reported $165.4M in net income over the trailing twelve months, a 32.4% net margin.

What are ADMA Biologics's profit margins?

Gross margin is 61.3% and operating margin is 42.1%, with a 32.4% net margin.

What is ADMA Biologics's earnings per share?

ADMA Biologics's diluted EPS over the trailing twelve months is $0.68.

Where does ADMA Biologics's income statement data come from?

Every line is extracted from ADMA Biologics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

ADMA Biologics ADMA Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Total revenue	$510.17M+19.6%	$426.45M+65.2%	$258.22M+67.6%	$154.08M+90.4%
Total cost of revenue	$217.41M+5.1%	$206.9M+22.2%	$169.27M+42.5%	$118.82M+48.9%
Gross profit	$292.77M+33.3%	$219.55M+147%	$88.94M+152%	$35.27M+2,906%
Gross margin	57.4%+5.9pp	51.5%+17.0pp	34.4%+11.6pp	22.9%+21.4pp
Research and development	$4.76M+163%	$1.81M-45.1%	$3.3M-8.7%	$3.61M-0.9%
Selling, general and administrative	$91.58M+23.6%	$74.12M+25.6%	$59.02M+12.5%	$52.46M+22.3%
Selling and marketing	$3.1M+14.8%	$2.7M-18.2%	$3.3M—	——
Total operating expenses	$101.32M+25.8%	$80.57M+19.7%	$67.31M-9.8%	$74.63M+25.3%
Operating income	$191.44M+37.7%	$138.98M+542%	$21.63M+155%	-$39.37M+32.6%
Operating margin	37.5%+4.9pp	32.6%+24.2pp	8.4%+33.9pp	-25.5%+46.6pp
Interest expense	$7.11M-49.0%	$13.93M-44.3%	$25.03M+29.8%	$19.28M+47.7%
Other income (expense), net	-$8.79M+33.8%	-$13.27M+73.4%	-$49.87M-87.9%	-$26.54M-99.9%
Income before income taxes	$182.66M+45.3%	$125.71M+545%	-$28.24M+57.1%	-$65.9M—
Income tax expense	$35.73M+150%	-$71.96M—	$0—	$0—
Net income	$146.93M-25.7%	$197.67M+800%	-$28.24M+57.1%	-$65.9M+8.0%
Net margin	28.8%-17.6pp	46.4%+57.3pp	-10.9%+31.8pp	-42.8%+45.7pp
Diluted earnings per share	$0.60-26.8%	$0.82+731%	-$0.13+61.8%	-$0.34+33.3%
EBITDA	$199.34M+35.9%	$146.68M+402%	$29.23M+191%	-$32.25M+39.0%
EBITDA margin	39.1%+4.7pp	34.4%+23.1pp	11.3%+32.3pp	-20.9%+44.4pp
EBIT	$191.44M+37.7%	$138.98M+542%	$21.63M+155%	-$39.37M+32.6%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about ADMA Biologics.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ADMA Biologics's revenue?: ADMA Biologics (ADMA) generated $509.9M in revenue over the trailing twelve months, up 11.0% year over year.
Is ADMA Biologics profitable?: ADMA Biologics reported $165.4M in net income over the trailing twelve months, a 32.4% net margin.
What are ADMA Biologics's profit margins?: Gross margin is 61.3% and operating margin is 42.1%, with a 32.4% net margin.
What is ADMA Biologics's earnings per share?: ADMA Biologics's diluted EPS over the trailing twelve months is $0.68.
Where does ADMA Biologics's income statement data come from?: Every line is extracted from ADMA Biologics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.